Sanjay K. Kakkar
Amministratore Delegato presso Tranquis Therapeutics, Inc.
Provenienza dei contatti di primo grado di Sanjay K. Kakkar
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Trigen Holdings AG
 Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Trigen Holdings AG develops drugs focusing on thrombosis and vascular dysfunction. Its product pipeline includes clinical stage candidates, TGN 255, TGN 167 and PR-15. The company has offices in London. Trigen Holdings was founded in 2005 and is headquartered in Martinsried, Germany.
11
| Extinct | Miscellaneous Commercial Services | 11 |
Tranquis Therapeutics, Inc.
 Tranquis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tranquis Therapeutics, Inc. discovers and develops novel immuno-therapeutics for neurological diseases. It offers treatment for central nervous system (CNS) disorders, including Amyotrophic Lateral Sclerosis, Parkinson 's disease, Alzheimer?s Disease, and age-related neuropathology. The company was founded by Chih-Ping Liu and Khoa D. Nguyen in June 2016 and is headquartered in Menlo Park, CA.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Sanjay K. Kakkar tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BIO-WORKS TECHNOLOGIES AB | Biotechnology | Chairman Chairman | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree | |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Undergraduate Degree Director/Board Member | |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor Private Equity Investor | |
| SYMETIS SA | Biotechnology | Director/Board Member Director/Board Member | |
| University of Uppsala | College/University | Undergraduate Degree Doctorate Degree | |
Karolinska Institutet University Press AB
 Karolinska Institutet University Press AB Publishing: Books/MagazinesConsumer Services Karolinska Institutet University Press AB is a Swedish publishing company that specializes in books. | Publishing: Books/Magazines | Chairman | |
| Sls Ventures AB | Director/Board Member | ||
| Medical Prognosis Institute, Inc. | Director/Board Member | ||
| Mordin AB | Corporate Officer/Principal | ||
| Bioworks AB | Chairman | ||
| Galecto Biotech AB | Chairman | ||
Eir Ventures Partners AB
 Eir Ventures Partners AB Investment ManagersFinance Eir Ventures Partners AB (Eir Ventures) is an independent venture capital firm founded in 2020 by Dr Magnus Persson, Dr Stephan Christgau, Andreas Segerros and Dr Amanda Hayward. The firm is headquartered in Stockholm with an additional office in Copenhagen, Denmark. | Investment Managers | Chairman | |
| P O Persson i Lidingö AB | Director/Board Member | ||
| Duomedix AB | Corporate Officer/Principal | ||
| Merigen AB | Corporate Officer/Principal | ||
3i Nordic Plc
 3i Nordic Plc Investment ManagersFinance 3i Nordic Plc (3i Nordic) is the Swedish venture capital subsidiary of 3i Group Plc (LSE: III) in Great Britain. Formerly known as Atle AB, founded in 1993, the firm was acquired by 3i in 2001 and renamed 3i Nordic. Located in Stockholm, 3i Nordic utilizes specialized 3i Group resources to provide financial experience, sector knowledge, company management practice and access to 3i's network of international contacts to investee companies. 3i Nordic is part of the 3i Nordic investment team which includes investment professionals from the Helsinki and Copenhagen offices. | Investment Managers | Private Equity Investor | |
| GALECTO, INC. | Pharmaceuticals: Major | Chairman | |
Carmel Pharma AB
 Carmel Pharma AB Electronic Equipment/InstrumentsElectronic Technology Carmel Pharma AB manufactures PhaSeal System, a clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs. The company expanded its safe handling initiatives to the U.S. market with the formation of Carmel Pharma, Inc., which operates a corporate office and distribution facility out of Columbus, OH. Carmel Pharma AB was founded in 1994 and is headquartered in Gothenburg, Sweden. | Electronic Equipment/Instruments | Director/Board Member | |
Global Medical Investments GMI AB
 Global Medical Investments GMI AB Financial ConglomeratesFinance Global Medical Investments GMI AB establishes and operates cancer centers in developing countries. It engages in the development and support of cancer management programs and cancer treatment clinics. The firm is an investment and project development company. It also secures contracts with health insurance companies and healthcare providers for private and state-run companies and government insurance agencies. The company was founded by Bror Thomas Pollare on July 24, 2009 and is headquartered in Solna, Sweden. | Financial Conglomerates | Chief Executive Officer | |
QuiaPEG Pharmaceuticals AB
 QuiaPEG Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology QuiaPEG Pharmaceuticals AB operates as biotech company developing biopharmaceuticals based on a proprietary PEGylation technology platform. The firm’s technology is applicable on proteins, peptides, and small molecules. It develops novel long-acting biopharmaceuticals for the treatment of metabolic disorders. The company was founded by Hans Marcus Bosson in 2012 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman | |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Biotechnology | Chairman | |
| Oncolution AB | Chief Executive Officer | ||
3i Plc
 3i Plc Financial ConglomeratesFinance 3i Plc operates as an private equity firm and provides investment advice. The company was founded on July 21, 1945 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Corporate Officer/Principal | |
| MENDUS AB | Biotechnology | Director/Board Member | |
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Director/Board Member | |
| Karolinska Institutet Information AB | Chairman | ||
Albumedix A/S
 Albumedix A/S Pharmaceuticals: MajorHealth Technology Albumedix A/S is a Danish biotechnology company. The private company is based in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Hip Health Innovation Platform AB
 Hip Health Innovation Platform AB Packaged SoftwareTechnology Services Hip Health Innovation Platform AB develops integration tools and applications for the healthcare industries. The private company is based in Stockholm, Sweden. | Packaged Software | Chairman | |
Karolinska Institutet Support AB
 Karolinska Institutet Support AB Miscellaneous Commercial ServicesCommercial Services Karolinska Institutet Support AB is a Swedish company that engages in research and development of framework activities in institutes. The private company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Karolinska Institutet Housing AB
 Karolinska Institutet Housing AB Real Estate DevelopmentFinance Karolinska Institutet Housing AB provides accommodation for international students and guest researchers at Karolinska Institutet. The private company is based in Stockholm, Sweden. The Swedish company offers furnished apartments and rooms in several areas to incoming international students and guest researchers. The maximum rental time is limited as the company is intended to be a first place to stay. The company does not own any of the housing areas or buildings but contracts are always signed between the company and the tenant. | Real Estate Development | Director/Board Member | |
Karolinska Institutet Holding AB
 Karolinska Institutet Holding AB Investment Trusts/Mutual FundsMiscellaneous Part of Karolinska Institutet Holding AB, Nätverk Karolinska Institutet Science Park AB (KISP) facilitates interaction between academia and industry on Campus Solna. The company is based in Solna, Sweden. KISP collaborates closely with Karolinska Institutet, Akademiska Hus, and AWL to organize seminars, workshops, and networking events that help researchers, startups, and established companies connect and gain new insights. The CEO of the Swedish company is Karl Johan Ingvar Weigelt. | Investment Trusts/Mutual Funds | Chief Executive Officer | |
Karolinska Institutet Science Park
 Karolinska Institutet Science Park Real Estate DevelopmentFinance Karolinska Institutet Science Park operates a science park that provides infrastructure and conference facilities. The private company is based in Solna, Sweden. | Real Estate Development | Director/Board Member | |
| KCIF Fund Management AB | Director/Board Member | ||
Själbådan AB
 Själbådan AB Financial ConglomeratesFinance Själbådan AB is a private company based in Stockholm, Sweden that provides investment services. | Financial Conglomerates | Director/Board Member | |
Gyros Protein Technologies Holding AB
 Gyros Protein Technologies Holding AB Electronic Equipment/InstrumentsElectronic Technology Part of Mesa Laboratories, Inc., Gyros Protein Technologies Holding AB is a Swedish company that manufactures measurement, testing and navigation equipment. The company is based in Stockholm, Sweden. | Electronic Equipment/Instruments | Director/Board Member | |
Perma Ventures AB
 Perma Ventures AB Investment ManagersFinance Perma Ventures AB provides financial advisory services. The private company is based in Stockholm, Sweden. | Investment Managers | Director/Board Member | |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
| CANTARGIA AB | Pharmaceuticals: Major | Chairman | |
| Healthcap III Sidefund GP AB | Investment Managers | Director/Board Member | |
| ABLIVA AB | Pharmaceuticals: Major | Director/Board Member | |
Attgeno AB
 Attgeno AB Pharmaceuticals: MajorHealth Technology ATTGENO AB develops, manufactures, and trades pharmaceutical drugs and electronic apparatus. Its product, Supernitro, is a vasodilator indicated for the treatment of acute pulmonary hypertension associated with major cardiac surgery. The company is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman | |
| AEROCRINE AB | Electronic Equipment/Instruments | Founder | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member | |
| Pharmaceuticals Sales & Development AB | Director/Board Member | ||
| INITIATOR PHARMA A/S | Pharmaceuticals: Major | Chairman |
Statistiche
Distribuzione geografica
| Svezia | 40 |
| Stati Uniti | 4 |
| Germania | 4 |
| Danimarca | 4 |
| Svizzera | 2 |
Settori
| Health Technology | 17 |
| Finance | 13 |
| Consumer Services | 5 |
| Electronic Technology | 4 |
| Technology Services | 2 |
Posizioni
| Director/Board Member | 109 |
| Chairman | 47 |
| Corporate Officer/Principal | 29 |
| Independent Dir/Board Member | 17 |
| Founder | 10 |
Contatti più connessi
- Borsa valori
- Insiders
- Sanjay K. Kakkar
- Connessioni Società
